Moreover, PEDF downregulates the expression of both c-FLIP mRNA and protein through p38 kinase signaling; therefore, in addition to its antiangiogenic nature towards endothelial cells, it may also influence the survival of HCC cells. Here, CFLAR is linked to hepatocellular carcinoma.